125 related articles for article (PubMed ID: 3457608)
1. Disappearance of cytogenetic abnormalities and clinical remission during therapy with 13-cis-retinoic acid in a patient with myelodysplastic syndrome: inhibition of growth of the patient's malignant monocytoid clone.
Abrahm J; Besa EC; Hyzinski M; Finan J; Nowell P
Blood; 1986 May; 67(5):1323-7. PubMed ID: 3457608
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
Nagler A; Rikilis I; Tatarsky I; Fabian I
J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
[TBL] [Abstract][Full Text] [Related]
3. 13-cis-Retinoic acid treatment in patients with myelodysplastic syndrome.
Leoni F; Ciolli S; Longo G; Messori A; Ferrini PR
Acta Haematol; 1988; 80(1):8-12. PubMed ID: 3135696
[TBL] [Abstract][Full Text] [Related]
4. Absent clinical effects of retinoic acid and isoretinoin treatment in the myelodysplastic syndrome.
Hast R; Axdorph S; Laurén L; Reizenstein P
Hematol Oncol; 1989; 7(4):297-301. PubMed ID: 2737610
[TBL] [Abstract][Full Text] [Related]
5. Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxyvitamin D3 in the myelodysplastic syndromes.
Swanson G; Picozzi V; Morgan R; Hecht F; Greenberg P
Blood; 1986 Apr; 67(4):1154-61. PubMed ID: 3513868
[TBL] [Abstract][Full Text] [Related]
6. 13-cis retinoic acid treatment for myelodysplastic syndromes.
Picozzi VJ; Swanson GF; Morgan R; Hecht F; Greenberg PL
J Clin Oncol; 1986 Apr; 4(4):589-95. PubMed ID: 3514807
[TBL] [Abstract][Full Text] [Related]
7. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of differentiation and proliferation of colony-stimulating factor-induced clonal growth of normal human marrow cells in vitro by retinoic acid.
Bradley EC; Ruscetti FW; Steinberg H; Paradise C; Blaine K
J Natl Cancer Inst; 1983 Dec; 71(6):1189-92. PubMed ID: 6606727
[TBL] [Abstract][Full Text] [Related]
9. Effect of 13-cis-retinoic acid on survival of patients with myelodysplastic syndrome.
Clark RE; Jacobs A; Lush CJ; Smith SA
Lancet; 1987 Apr; 1(8536):763-5. PubMed ID: 2882180
[TBL] [Abstract][Full Text] [Related]
10. Phase I-II study of 13-cis-retinoic acid in myelodysplastic syndrome.
Greenberg BR; Durie BG; Barnett TC; Meyskens FL
Cancer Treat Rep; 1985 Dec; 69(12):1369-74. PubMed ID: 3865701
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
[TBL] [Abstract][Full Text] [Related]
12. Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all-trans-retinoic acid, granulocyte colony-stimulating factor, erythropoietin and alpha-tocopherol.
Ganser A; Maurer A; Contzen C; Seipelt G; Ottmann OG; Schadeck-Gressel C; Kolbe K; Haas R; Zander C; Reutzel R; Hoelzer D
Ann Hematol; 1996 Apr; 72(4):237-44. PubMed ID: 8624378
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome.
Clark RE; Ismail SA; Jacobs A; Payne H; Smith SA
Br J Haematol; 1987 May; 66(1):77-83. PubMed ID: 3297129
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study.
Aul C; Runde V; Gattermann N
Blood; 1993 Nov; 82(10):2967-74. PubMed ID: 8219188
[TBL] [Abstract][Full Text] [Related]
15. Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF.
Nagler A; Binet C; Mackichan ML; Negrin R; Bangs C; Donlon T; Greenberg P
Blood; 1990 Oct; 76(7):1299-307. PubMed ID: 1698477
[TBL] [Abstract][Full Text] [Related]
16. Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone.
Sadek I; Zayed E; Hayne O; Fernandez L
Am J Hematol; 2000 Aug; 64(4):306-10. PubMed ID: 10911385
[TBL] [Abstract][Full Text] [Related]
17. A hematological remission by clonal hematopoiesis after treatment with recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin in a patient with therapy-related myelodysplastic syndrome.
Bessho M; Itoh Y; Kataumi S; Kawai N; Matsuda A; Jinnai I; Saitoh M; Hirashima K; Minamihisamatsu M
Leuk Res; 1992; 16(2):123-31. PubMed ID: 1545564
[TBL] [Abstract][Full Text] [Related]
18. Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol.
Besa EC; Abrahm JL; Bartholomew MJ; Hyzinski M; Nowell PC
Am J Med; 1990 Dec; 89(6):739-47. PubMed ID: 2252043
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
Estey EH; Thall PF; Pierce S; Cortes J; Beran M; Kantarjian H; Keating MJ; Andreeff M; Freireich E
Blood; 1999 Apr; 93(8):2478-84. PubMed ID: 10194425
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute promyelocytic leukaemia relapsing after allogeneic bone marrow transplantation with all-trans-retinoic acid: suppression of the leukaemic clone.
Bashford J; Szer J; Wiley JS; Buckley M; Garson OM; Van der Weyden MB
Br J Haematol; 1991 Oct; 79(2):331-4. PubMed ID: 1958492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
